Second trimester maternal serum analytes in triploid pregnancies: Correlation with phenotype and sex chromosome complement

Prenatal Diagnosis

Volumn 21, Issue 8, 2001, Pages 680-686

  Abrams, Debra J ^a,d   Aronoff, Amy R ^b   Berend, Sue Ann ^c   Roa, Benjamin B ^c   Shaffer, Lisa G ^c   Geier, Mark R ^a  

^a Genetic Centers of America   (United States)

^b Departments of Molecular Medicine   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Diandric; Digynic; Maternal serum screening; Partial mole; Placenta

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A;

ADULT; ARTICLE; DOWN SYNDROME; FEMALE; FETUS; HUMAN; HYDATIDIFORM MOLE; KARYOTYPE 47,XXX; KARYOTYPE 47,XXY; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEURAL TUBE DEFECT; PHENOTYPE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEX CHROMOSOME; TRIPLOIDY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; INHIBINS; PHENOTYPE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; SEX CHROMOSOMES; TRISOMY;

EID: 0034855250     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.139     Document Type: Article

References (58)

1. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy
2. Prenatal detection of triploidy
3. Trisomy 16 and trisomy 16 mosaicism: A review
4. Prenatal diagnosis of diverse chromosome abnormalities in a population of patients identified by triple-marker testing as screen positive for Down syndrome
5. Medians for second trimester maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups
6. Elevated maternal serum alpha-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier
7. Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses
8. Serum human chorionic gonadotropin levels throughout pregnancy
9. Prenatal screening for trisomy 18 in the second trimester
10. Partial molar pregnancy associated with severe hypertension
11. Highly abnormal maternal serum inhibin and (beta)-human chorionic gonadotropin levels along with severe HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome at 17 weeks' gestation with triploidy
12. Maternal origin of extra set of chromosomes in third trimester triploid fetuses
13. Placental insufficiency as a possible cause of low maternal serum human chorionic gonadotropin and low maternal serum unconjugated estriol levels in triploidy
14. Prenatal ascertainment of triploidy by maternal serum alpha-fetoprotein screening
15. Triploidy: Pregnancy complications and clinical findings in seven cases
16. Triploidy in the second trimester associated with very low levels of MS-AFP, MS-HCG and MS-uE3
17. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and hCG screening
18. Digynic triploid infant surviving for 46 days
19. Inhibin and related peptides in pregnancy
20. Fetal triploidy associated with elevated maternal serum alpha feto-protein
21. Human triploidy: Relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole
22. Partial moles: From postnatal to prenatal diagnosis
23. Ultrasound assessment of placental abnormalities
24. Chromosomally abnormal early ongoing pregnancies: Correlation of ultrasound and placental histological findings
25. Origin of triploidy in human abortuses
26. Triploid fetus: An important consideration in the evaluation of very high maternal serum alpha-fetoprotein
27. The advantages of using triple-marker screening for chromosome abnormalities
28. What factors regulate HCG production in Down syndrome pregnancies?
29. Significance of very low maternal serum human chorionic gonadotropin in prenatal diagnosis of triploidy
30. Genetic studies on hydatidiform moles. I. The origin of parial moles
31. Sonographic features of the triploid fetus
32. Low maternal serum human chorionic gonadotropin and unconjugated oestriol in a triploid pregnancy
33. Two different phenotypes of fetuses with chromosomal triploidy: Correlation with parental origin of the extra haploid set
34. Triploidy with an extra sex chromosome and elevated alpha-fetoprotein levels
35. Early prenatal ultrasonic detection of fetal triploidy syndrome
36. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of the subsequent fetal and neonatal deaths
37. Elevated maternal serum alpha-fetoprotein in triploidy
38. Maternal serum hCG levels in triploidy: Variability and need to consider molar tissue
39. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin
40. Localization, secretion and action of inhibin in human placenta
41. Maternal serum alpha-fetoprotein and fetal triploidy
42. Trisomy 21 placentas: Histopathological and immunocytochemical findings using proliferating cell nuclear antigen
43. Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions
44. Risk of preeclampsia in second-trimester triploid pregnancies
45. Multiple-marker screening in pregnancies with hydropic and non-hydropic Turner syndrome
46. The detection of non-immune hydrops through second-trimester maternal serum screening
47. Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy
48. Eclampsia in association with partial molar pregnancy and congenital abnormalities
49. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole
50. Human triploidy: Association with partial hydatidiform moles and nonmolar conceptuses
51. Identification of triploid genome by fluorescence microscopy
52. Maternal serum screening and triploidy
53. Dispermy as the origin of partial moles as well as a nonmolar conception
54. Four-marker serum screening for Down's syndrome
55. Prenatal screening for Down's syndrome using inhibin-A as a serum marker
56. Risk of fetal chromosomal abnormalities in patients with elevated maternal serum alpha-fetoprotein
57. The clinical syndrome of triploidy
58. 'Dual positivity' for neural tube defects and Down syndrome at maternal serum screening: Gestational outcome